Gals Bio
Gals Bio is pioneering a new category in women’s health and wellness called Fem-Wearables.
Company Overview
Snapshot
Founded in October 2015 by Hilla Shaviv, Gals Bio operates with 1–10 employees. The company has raised $1.96M across two funding rounds from two investors, developing innovative Fem-Wearables for women's health. In January 2022, Gals Bio secured equity crowdfunding from PipelBiz.
Business overview
Gals Bio is a Health Tech & Life Sciences company focused on pioneering Fem-Wearables, a new category in women's health and wellness. The company leverages the unique vaginal environment and integrates AI-powered analysis to provide personalized, early, and accessible home health solutions. These solutions, including their first device Tulipon, are designed for rapid screening, monitoring, and therapeutic care, serving markets across the Americas, Europe, and globally.
Strategic signal
In January 2022, Gals Bio was featured in Haaretz for its innovative approach to femtech, specifically highlighting its new smart tampon. This signals the company's potential to disrupt the women's health market by offering advanced, non-invasive diagnostic tools, attracting attention to its novel Fem-Wearables category and its commitment to early detection and personalized care.
Log in to access full profile ›Company Intelligence Q&A
- When was Gals Bio founded?
- Gals Bio was founded in October 2015 by Hilla Shaviv.
- What is Gals Bio's primary product?
- Gals Bio's primary product is Tulipon, a device designed for clean collection of vaginal secretions for cancer screening, integrating AI-powered liquid biopsy analysis.
- How much capital has Gals Bio raised?
- Gals Bio has raised a total of $1.96M across two funding rounds.
- What is the focus of Gals Bio's technology?
- Gals Bio focuses on Fem-Wearables, leveraging the vaginal environment and AI-powered analysis to provide personalized, early, and accessible home health solutions for women's health needs.